# Aemetis, Inc: overview AMTX · Nasdaq · CIK 738214 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/amtx.md) · [Financials](/companies/amtx/financials.md) · [Filings](/companies/amtx/filings.md) · [Insiders](/companies/amtx/insiders.md) Latest reported revenue: [$62.7m](/filings/0001437749-26-026052.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 6, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax, accession 0001437749-26-026052). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [81.4](/filings/0001437749-25-033667.md) | [47.0 d](/filings/0001437749-26-008289.md) | [42.9](/filings/0001437749-26-015362.md) | [52.2](/filings/0001437749-26-026052.md) | [59.2](/filings/0001437749-25-033667.md) | [43.3 d](/filings/0001437749-26-008289.md) | [54.6](/filings/0001437749-26-015362.md) | [62.7](/filings/0001437749-26-026052.md) | | Gross margin | % | [4.8%](/filings/0001437749-25-033667.md) | [(4.3%) d](/filings/0001437749-26-008289.md) | [(11.8%)](/filings/0001437749-26-015362.md) | [(6.4%)](/filings/0001437749-26-026052.md) | [(0.1%)](/filings/0001437749-25-033667.md) | [17.8% d](/filings/0001437749-26-008289.md) | [5.0%](/filings/0001437749-26-015362.md) | [21.6%](/filings/0001437749-26-026052.md) | | Operating margin | % | [(4.8%)](/filings/0001437749-25-033667.md) | [(28.7%) d](/filings/0001437749-26-008289.md) | [(36.3%)](/filings/0001437749-26-015362.md) | [(20.4%)](/filings/0001437749-26-026052.md) | [(14.4%)](/filings/0001437749-25-033667.md) | [(5.7%) d](/filings/0001437749-26-008289.md) | [(11.6%)](/filings/0001437749-26-015362.md) | [9.2%](/filings/0001437749-26-026052.md) | | Net margin | % | [(22.0%)](/filings/0001437749-25-033667.md) | [(34.5%) d](/filings/0001437749-26-008289.md) | [(57.2%)](/filings/0001437749-26-026052.md) | [(44.8%)](/filings/0001437749-26-026052.md) | [(40.1%)](/filings/0001437749-25-033667.md) | [(12.3%) d](/filings/0001437749-26-008289.md) | [(39.8%)](/filings/0001437749-26-026052.md) | [(14.9%)](/filings/0001437749-26-026052.md) | | Diluted EPS | $ per share | [(0.38)](/filings/0001437749-25-033667.md) | not reported | [(0.47)](/filings/0001437749-26-015362.md) | [(0.41)](/filings/0001437749-26-026052.md) | [(0.37)](/filings/0001437749-25-033667.md) | not reported | [(0.33)](/filings/0001437749-26-015362.md) | [(0.13)](/filings/0001437749-26-026052.md) | | Free cash flow | $m | [(9.5) d](/filings/0001437749-25-033667.md) | [(19.4) d](/filings/0001437749-26-008289.md) | [(1.7)](/filings/0001437749-26-015362.md) | [(9.3) d](/filings/0001437749-26-026052.md) | [(1.0) d](/filings/0001437749-25-033667.md) | [(10.8) d](/filings/0001437749-26-008289.md) | [(17.1)](/filings/0001437749-26-015362.md) | [(10.4) d](/filings/0001437749-26-026052.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [212](/filings/0001654954-22-002831.md) | [28.1](/filings/0001437749-24-010002.md) | [77.2](/filings/0001437749-24-010002.md) | [268](/filings/0001437749-26-008289.md) | [198](/filings/0001437749-26-008289.md) | | Gross margin | % | [3.7%](/filings/0001437749-23-005872.md) | [(19.7%)](/filings/0001437749-24-010002.md) | [2.6%](/filings/0001437749-25-007768.md) | [(0.2%)](/filings/0001437749-26-008289.md) | [(0.4%)](/filings/0001437749-26-008289.md) | | Operating margin | % | [(7.5%)](/filings/0001437749-23-005872.md) | [(122.4%)](/filings/0001437749-24-010002.md) | [(48.5%)](/filings/0001437749-25-007768.md) | [(15.1%)](/filings/0001437749-26-008289.md) | [(18.8%)](/filings/0001437749-26-008289.md) | | Net margin | % | [(22.2%)](/filings/0001437749-23-005872.md) | [(383.3%)](/filings/0001437749-24-010002.md) | [(60.1%)](/filings/0001437749-25-007768.md) | [(32.7%)](/filings/0001437749-26-008289.md) | [(39.0%)](/filings/0001437749-26-008289.md) | | Diluted EPS | $ per share | [(1.54)](/filings/0001437749-23-005872.md) | [(3.12)](/filings/0001437749-24-010002.md) | [(1.22)](/filings/0001437749-25-007768.md) | [(1.91)](/filings/0001437749-26-008289.md) | [(1.28)](/filings/0001437749-26-008289.md) | | Free cash flow | $m | [(47.3)](/filings/0001437749-23-005872.md) | [(62.0)](/filings/0001437749-24-010002.md) | [(19.3)](/filings/0001437749-25-007768.md) | [(53.2)](/filings/0001437749-26-008289.md) | [(22.7)](/filings/0001437749-26-008289.md) | - Revenue. XBRL Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/amtx/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $6.5m | 3,970,470 | | Added +3,337,254 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $4.9m | 2,991,239 | | Added +356,586 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $2.8m | 1,720,035 | | Added +989,419 | | [Grantham, Mayo, Van Otterloo & Co. LLC](/funds/1352662.md) | 2026-06-30 | $1.7m | 1,064,317 | | Added +14,300 | | [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $1.2m | 726,199 | | Added +424,300 | | [D. E. Shaw & Co., Inc.](/funds/1009207.md) | 2026-06-30 | $1.0m | 623,028 | | Added +77,599 | | [NORTHERN TRUST CORP](/funds/73124.md) | 2026-06-30 | $833.1k | 507,989 | | Added +372,755 | | [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $725.5k | 442,363 | | New +442,363 | | [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $719.9k | 438,939 | | Added +60,836 | | [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $657.2k | 400,722 | | Added +19,780 | ## Recent filings [All 750 filings](/companies/amtx/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-08-06 | 08:31 ET | [10-Q](/filings/0001437749-26-026052.md) | Quarterly report, period 2026-06-30 | 0001437749-26-026052 | | 2026-08-06 | 08:30 ET | [8-K](/filings/0001437749-26-026051.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-026051 | | 2026-05-26 | 17:01 ET | [8-K](/filings/0001437749-26-018382.md) | 5.07 Shareholder vote results | 0001437749-26-018382 | | 2026-05-07 | 08:54 ET | [10-Q](/filings/0001437749-26-015362.md) | Quarterly report, period 2026-03-31 | 0001437749-26-015362 | | 2026-05-07 | 08:45 ET | [8-K](/filings/0001437749-26-015360.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-015360 | | 2026-04-07 | 16:55 ET | [DEF 14A](/filings/0001437749-26-011626.md) | Proxy statement, period 2026-05-20 | 0001437749-26-011626 | | 2026-03-16 | 16:18 ET | [8-K](/filings/0001437749-26-008426.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001437749-26-008426 | | 2026-03-16 | 18:14 ET | [10-K](/filings/0001437749-26-008289.md) | Annual report, period 2025-12-31 | 0001437749-26-008289 | | 2026-03-12 | 08:30 ET | [8-K](/filings/0001437749-26-007834.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-007834 | | 2026-02-19 | 20:38 ET | [8-K](/filings/0001437749-26-004619.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-004619 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001437749-26-008289.md), filed Mar 16, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/db47751f-23e9-4c60-ad5f-9f3b75d83fd0) ## About the filer - CIK: 738214 - Tickers: AMTX - Exchange: Nasdaq - SIC code: 2860 Industrial Organic Chemicals - State of incorporation: NV - Filer category: Accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:23 ET. No prices; not investment advice.